CD1-MR1 2025 , ,
Presentations this author is a contributor to:
Single-cell analysis results of the patient's blood in the phase I clinical trial of allogeneic iPS cell-derived invariant NKT cell monotherapy (#151)
12:30 PM
Takahiro Aoki
Lunch & Poster Session 2
Antibody-dependent cellular cytotoxicity of iPS cell-derived natural killer T cells by anti-GD2 mAb for neuroblastoma (#20)
4:47 PM
Katsuhiro Nishimura
Lightning Talks 1